Peptide delivery system The development of effective protein and peptide drug delivery systems is crucial for harnessing the therapeutic potential of these biomolecules作者：WW Yang·2012·被引用次数：230—This review focuses on the use of different polymerdrug delivery systemsand their advancement toward clinical applications.. Proteins and peptides, while offering high efficacy and lower toxicity compared to traditional chemical drugs, face significant challenges in their delivery due to their inherent instability, large molecular size, and susceptibility to enzymatic degradation.In recent years, much attention has been drawn to new and promising applications of alginates in pharmacy and medicine, e.g. indrugorprotein delivery, cell ... This presentation explores the landscape of protein and peptide drug delivery, highlighting key advancements, formulation strategies, and the ongoing quest for improved drug delivery systems that overcome these obstacles.
Proteins and peptides are complex macromolecules that play vital roles in biological processes. As therapeutic agents, they offer targeted action and reduced side effectsDRUG DELIVERY SYSTEMS PROTEIN AND PEPTIDE .... However, their journey from administration to the target site is fraught with difficultiesAdvances in nanoscale carrier-based approaches to .... The primary hurdle is their susceptibility to degradation by proteases in the gastrointestinal tract, rendering oral administration largely ineffective for many of these drugs. Furthermore, their large size can impede absorption across biological membranes.Reservoir-Based Polymer Drug Delivery Systems Consequently, the parenteral route (e.g., injection) has historically been the most efficient way for systemic delivery of proteins and peptidesVarious drug delivery systems for proteins and peptidesincluding polymer-based, liposome-based, hydrogel-based, and emulsion-based systems.. This necessitates frequent injections, impacting patient compliance and quality of life.
To address these limitations, significant research has focused on developing novel drug delivery systems (DDS) that can protect proteins and peptides from degradation, enhance their absorption, and enable alternative routes of administration. These advancements often leverage various technologies:
* Nanocarrier-Based Systems: Nanocarrier-based protein/peptide (P/P) delivery systems are emerging as a promising avenue. These include liposomes, polymeric nanoparticles, and micelles, which encapsulate the therapeutic protein or peptide, shielding it from the harsh biological environment. These carriers can also be engineered to target specific tissues or cells, further improving therapeutic outcomes and reducing off-target effects2012年1月11日—Presentation Transcript. 1.Protein Drug Delivery SystemTeam Members: Austin Ramme- Team Leader Michael Haggerty- BSAC Andrew Neumann- BWIG .... This approach is particularly being explored for pulmonary drug delivery and crossing the blood-brain barrier.作者：NC Giri·2022·被引用次数：12—Protein and peptide-based drugs have great potential applications as therapeutic agentssince they have higher efficacy and lower toxicity than chemical ...
* Self-Assembled Peptide Nanomaterials: Self-assembled peptide nanomaterials offer unique drug delivery capabilities.Protein Drug Delivery System - PPT These systems are formed from peptides that spontaneously assemble into ordered nanostructures, creating a matrix for drug loading and controlled release作者：C Zhang·2023·被引用次数：24—The nano-baseddrug deliveryplatform has been introduced toPPT deliveryfor the purpose of improved solubility, enhanced efficacy, and reduced toxicity.. Their biocompatibility and biodegradability make them attractive candidates for therapeutic applications.
* Polymer-Based Systems: Various reservoir-based polymer drug delivery systems and other polymer matrices are designed for sustained or controlled release of proteins and peptides.In this review, three typical design strategies ofself-assembled peptide nanomaterials for drug deliveryhave been summarized. These can include biodegradable polymers that gradually degrade, releasing the encapsulated drug over an extended period.
* Lipid-Based Formulations: Multifunctional self-emulsifying drug delivery systems and other lipid-based formulations are being investigated for their potential to improve the solubility and oral bioavailability of peptide and protein drugs.
Beyond parenteral administration, considerable effort is directed towards developing non-invasive routes for protein and peptide drug delivery.
* Oral Delivery: While challenging, advancements in oral and transdermal peptide drug delivery are being made. This involves strategies like enteric coatings, permeation enhancers, and enzyme inhibitors to protect the drugs in the GI tract and facilitate their absorptionReservoir-Based Polymer Drug Delivery Systems.
* Transdermal Delivery: Transdermal drug delivery systems offer a needle-free alternative2012年1月11日—Presentation Transcript. 1.Protein Drug Delivery SystemTeam Members: Austin Ramme- Team Leader Michael Haggerty- BSAC Andrew Neumann- BWIG .... Techniques such as microneedles, iontophoresis, and penetration enhancers are being explored to facilitate the passage of proteins and peptides across the skin.The document addresses theformulation and evaluation of protein and peptide drug delivery systems, discussing the barriers and methodologies for effective ...
* Pulmonary Delivery: The lungs provide a large surface area and rich vasculature, making them an attractive route for systemic delivery of macromolecules.PROTEIN AND PEPTIDE DRUG DELIVERY SYSTEM Inhaled protein and peptide formulations can offer rapid absorption and bypass first-pass metabolism.
The success of any protein and peptide drug delivery system hinges on meticulous formulation and evaluation. Key considerations include ensuring the stability and integrity of the protein or peptide during formulation and storage, achieving the desired release profile, and demonstrating efficacy and safety in preclinical and clinical studies.作者：C Zhang·2023·被引用次数：24—The nano-baseddrug deliveryplatform has been introduced toPPT deliveryfor the purpose of improved solubility, enhanced efficacy, and reduced toxicity. Techniques for evaluating these systems involve assessing drug loading efficiency, release kinetics, stability under various conditions, pharmacokinetic profiles, and ultimately, therapeutic effectiveness.
The field of protein and peptide drug delivery is continuously evolving. Future research is likely to focus on developing even more sophisticated delivery platforms, including smart drug delivery systems that respond to physiological cues, enhanced targeting strategies, and combination therapies. The ultimate goal is to make protein and peptide therapies more accessible, convenient, and effective for a wider range of diseases.
Join the newsletter to receive news, updates, new products and freebies in your inbox.